RAB40A antibody
Principal name
RAB40A antibody
Alternative names for RAB40A antibody
Rab-40A, RAR2A, Rar-2, Ras-related protein Rab-40A, SOCS box-containing protein RAR2A
SwissProt ID
Q8WXH6 (Human)
Gene ID
142684 (RAB40A)
Ncbi ID
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of RAB40A antibody
- Kit Component:
- - KN220169G1, RAB40A gRNA vector 1 in pCas-Guide vector
- KN220169G2, RAB40A gRNA vector 2 in pCas-Guide vector
- KN220169D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
General readings
Itoh,T., (2006) Genes Cells 11 (9), 1023-1037

Western Blot analysis of RAB40A expression in transfected 293T cell line (H00142684-T01) by RAB40A MaxPab polyclonal antibody.Lane 1: RAB40A transfected lysate(30.47 KDa).Lane 2: Non-transfected lysate.

Western Blot analysis of RAB40A expression in transfected 293T cell line (H00142684-T01) by RAB40A MaxPab polyclonal antibody.Lane 1: RAB40A transfected lysate(30.47 KDa).Lane 2: Non-transfected lysate.

Human HepG2; WB Suggested Anti-RAB40A Antibody Titration: 0.2-1 ug/ml. Positive Control: HepG2 cell lysate; RAB40A antibody - middle region (ARP52532_P050) in Human HepG2 cells using Western Blot
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP320169 | RAB40A |
||||
| Recombinant protein of human RAB40A, member RAS oncogene family (RAB40A) | |||||
![]() |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY408996 | RAB40A overexpression lysate |
|
![]() |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |



